In the race to find treatments for COVID-19, CP3 Director Dr. Walid Gellad reminds us in Wired, "No one study is the final word, especially when other trials are ongoing—and it’s not like the percentages with the outcome were exactly the same in the two groups here. The correct interpretation is as the authors wrote, which is that this study does not demonstrate benefit in prophylaxis. But it is incorrect to say that this study proves it doesn’t work."